Daily news about corporate social responsibility, ethics and sustainability
Tags (14) : clinical research
Cumulus Neuroscience Unveils Symbol Swap Alzheimer's Trial Data at AAIC 2026
07/15/2026 | Companies
AAIC 2026,
ADAS-Cog,
Alzheimer's Association International Conference,
Alzheimer's clinical trials,
Alzheimer's disease,
Alzheimer's pathology,
amyloid plaques,
BioHermes-002,
blood biomarkers,
Brian Murphy,
clinical research,
CNS trials,
CNS-101,
cognitive screening,
cognitive testing,
Cumulus Neuroscience,
decentralized clinical trials,
dementia research,
digital biomarkers,
digital cognitive assessment,
digital endpoints,
digital health,
EEG,
executive function,
Fastball i4i,
GAP,
Global Alzheimer's Platform,
James Rowe,
MCI,
mild cognitive impairment,
MMSE,
MoCA,
NeuLogiq Platform,
neuroscience,
neurotechnology,
patient recruitment,
plasma biomarkers,
precision medicine,
pTau-217,
remote patient monitoring,
Symbol Swap,
tau tangles,
Tina Sampath,
trial enrichment,
University of Cambridge
Creyos Highlights AI-Powered Cognitive Research at AAIC 2026
07/15/2026 | Companies
AAIC 2026,
Adrian Owen,
Alzheimer's Association International Conference,
Alzheimer's biomarkers,
Alzheimer's disease,
Alzheimer's research,
artificial intelligence in healthcare,
attention assessment,
Australia,
behavioral health,
biomarker analysis,
brain aging,
brain health,
brain research,
bushfire smoke exposure,
CDP study,
clinical research,
clinical validation,
cognitive assessment,
cognitive decline,
cognitive function,
cognitive impairment,
cognitive monitoring,
cognitive neuroscience,
cognitive performance,
cognitive screening,
cognitive testing,
Creyos,
Creyos Dementia Protocol,
dementia prevention,
dementia research,
dementia screening,
digital cognitive health,
digital diagnostics,
digital health technology,
early dementia detection,
environmental health,
health technology,
healthcare innovation,
healthy aging,
longitudinal study,
machine learning,
memory clinic,
Michelle Lupton,
MMSE,
neurocognitive assessment,
neurodegeneration,
neurological health,
neuropsychology,
neuroscience,
occupational health,
online cognitive testing,
particulate matter,
PISA study,
population health,
precision medicine,
preventive healthcare,
Prospective Imaging Study of Aging,
public health,
QIMR Berghofer,
R-FIRE study,
remote assessment,
rural firefighters,
scientific conference,
visuospatial working memory,
Western University,
wildfire smoke
SetPoint Expands FDA-Approved Rheumatoid Arthritis Therapy to North Carolina
06/29/2026 | Companies
AOCC,
Arthritis & Osteoporosis Consultants of the Carolinas,
autoimmune diseases,
autoimmune disorder treatment,
biologic therapies,
biotechnology,
Charlotte North Carolina,
chronic disease management,
chronic inflammation,
clinical research,
disease-modifying antirheumatic drugs,
DMARDs,
FDA approval,
healthcare innovation,
implantable medical device,
inflammation regulation,
medical devices,
medical technology,
neuroimmune modulation,
non-pharmacological treatment,
patient care,
RA treatment,
RESET-RA study,
rheumatoid arthritis,
rheumatology,
SetPoint Medical,
SetPoint System,
targeted RA therapies,
vagus nerve stimulation,
vagus nerve therapy
Yidu Tech Highlights AI’s Role in Accelerating Drug Development at Summer Davos 2026
06/25/2026 | Companies
AI agents in healthcare,
AI in medicine,
AI-powered healthcare,
artificial intelligence in healthcare,
biotechnology,
BruHealth,
Brunei healthcare,
clinical research,
clinical trial optimization,
clinical trials,
data sovereignty,
data standardization,
digital health,
digital transformation in healthcare,
disease knowledge graph,
drug development,
evidence-based medicine,
global health innovation,
global healthcare innovation,
Gong Yingying,
healthcare access,
healthcare AI,
healthcare analytics,
healthcare compliance,
healthcare data governance,
healthcare data infrastructure,
healthcare data management,
healthcare digitization,
healthcare ecosystem,
healthcare infrastructure,
healthcare innovation,
healthcare policy,
healthcare research,
healthcare technology,
healthcare transformation,
life sciences,
medical AI,
medical research,
medical technology,
Novartis,
patient recruitment,
pharmaceutical innovation,
pharmaceutical R&D,
pharmaceutical technology,
precision medicine,
real-world evidence,
Summer Davos,
Summer Davos 2026,
World Economic Forum,
Yidu Tech,
YiduCore
Nippon Shinyaku and Boston Children's Hospital Partner on Neurology Research
06/23/2026 | Companies
biotech partnership,
Boston Children's Hospital,
Boston Children's Hospital collaboration,
Cambridge Massachusetts,
clinical research,
drug discovery,
healthcare industry,
healthcare innovation,
innovative therapies,
Kyoto Japan,
life sciences,
medical innovation,
medical research,
neurological disorders,
neurological therapeutics,
neurology research,
neuroscience,
Nippon Shinyaku,
Nippon Shinyaku research initiative,
NS Pharma,
NS Pharma IRP,
Paramus New Jersey,
pharmaceutical collaboration,
pharmaceutical industry,
rare disease research,
rare disease treatment,
research partnership,
Sponsored Research Agreement,
therapeutic development,
unmet medical needs
Intensity Therapeutics Wins 2026 Pinnacle Award for INT230-6 Cancer Therapy
04/16/2026 | Companies
biotech awards,
biotech solutions,
biotechnology,
cancer therapy,
cancer treatment development,
cisplatin,
clinical research,
drug conjugation technology,
healthcare innovation,
immunotherapy enhancement,
INT230-6,
Intensity Therapeutics,
intratumoral injection,
oncology innovation,
pharmaceutical innovation,
Pinnacle Awards 2026,
SHAO molecule,
solid tumors,
tumor targeting,
vinblastine sulfate
Jazz Pharmaceuticals Showcases Epilepsy and Narcolepsy Research at AAN 2026
04/09/2026 | Companies
AAN 2026,
American Academy of Neurology,
behavioral symptoms,
cannabidiol,
clinical research,
cognitive function,
Dravet syndrome,
drug development,
DUET study,
EpiCom study,
Epidiolex,
epilepsy,
Jazz Pharmaceuticals,
Lennox-Gastaut syndrome,
medical conference,
narcolepsy,
neurological disorders,
neuroscience,
patient care,
Phase 3 trial,
rare diseases,
refractory epilepsy,
sleep disorders,
treatment outcomes,
tuberous sclerosis complex,
Xywav
Harbour BioMed Reports Positive Phase I Results for HBM9378 Antibody Therapy
03/23/2026 | Companies
antibody therapeutics,
biologics,
biotech innovation,
chronic obstructive pulmonary disease,
clinical research,
COPD,
drug development,
half-life extension,
Harbour BioMed,
HBM9378,
immune-oncology,
immunological disorders,
immunology,
Kelun-Biotech,
monoclonal antibody,
pharmacokinetics,
Phase I clinical trial,
respiratory medicine,
safety profile,
severe asthma,
SKB378,
TSLP inhibitor,
WIN378
Hyundai Bioscience Launches U.S. Phase 2 Trials for Broad-Spectrum Antiviral Xafty
01/15/2026 | Companies
antiviral drug development,
basket trial,
Biotech Showcase 2026,
biotechnology,
broad-spectrum antiviral,
clinical research,
COVID-19 variants,
dengue fever,
FDA IND application,
global health,
Hyundai Bioscience,
infectious diseases,
influenza,
multi-viral treatment,
pharmaceutical innovation,
Phase 2 clinical trials,
public health strategy,
RSV,
tripledemic,
viral epidemics,
virus prevention,
Xafty
Clover Biopharma Advances Phase 2 Trial for RSV Combination Vaccines
01/12/2026 | Companies
Australia clinical trial,
biotechnology company,
clinical research,
Clover Biopharmaceuticals,
combination vaccines,
global health,
hMPV vaccine,
immunogenicity,
infectious diseases,
older adults,
Phase 2 clinical trial,
PIV3 vaccine,
prefusion-stabilized F protein,
protein-based vaccines,
respiratory vaccines,
RSV vaccine,
Trimer-Tag technology,
vaccine development,
vaccine safety
How Kenvue Advances Oral, Skin, and Baby Care Through Science-Backed Innovations
08/05/2025 | Companies
Aveeno,
baby skincare,
clinical research,
collagen care,
colloidal oat,
consumer health,
dental hygiene,
dermatology,
diabetes care,
eczema relief,
emollients,
gingivitis,
gum health,
healthcare solutions,
hydration,
Kenvue,
LISTERINE,
Lubriderm,
NeoStrata,
Neutrogena,
newborn care,
oral health,
oral microbiome,
plaque reduction,
retinoids,
scientific innovation,
skin health,
skin longevity,
trust in science
Cinacalcet Dosing During Dialysis Improves SHPT Care and Adherence
07/31/2025 | Companies
calcium control,
chronic kidney disease,
cinacalcet,
clinical research,
DaVita,
dialysis,
dialysis medication,
end-stage kidney disease,
healthcare innovation,
healthcare outcomes,
hemodialysis,
in-center dosing,
medication adherence,
nephrology,
patient care,
phosphorus balance,
pill burden,
secondary hyperparathyroidism,
SHPT,
value-based care
Winn CIPP 2025: Empowering Future Clinical Researchers for Health Equity
07/17/2025 | Companies
Amgen,
Better Science For All,
Bristol Myers Squibb Foundation,
cancer equity,
cancer research,
clinical investigator training,
clinical research,
clinical trials diversity,
community health,
community-engaged research,
Fred Hutchinson Cancer Center,
future physician-scientists,
Gilead Sciences,
health disparities,
health equity,
healthcare innovation,
inclusive clinical trials,
medical education,
medical research opportunities,
medical student externship,
medical summer program,
mentorship in medicine,
research symposium,
Robert A. Winn Clinical Investigator Pathway Program,
translational research,
VCU Massey Comprehensive Cancer Center,
Winn CIPP
Enhancing Diversity in Clinical Trials: Why It Matters for Drug Development
01/15/2025 | Companies
clinical research,
clinical trial barriers,
clinical trial diversity,
clinical trial inclusion,
clinical trial participation,
clinical trial statistics,
clinical trials,
cultural competency,
diversity in clinical trials,
drug development,
ethnic diversity,
FDA guidelines,
health equity,
healthcare access,
healthcare disparities,
healthcare diversity,
medical research,
patient-centered development,
pharmaceutical industry,
Teva,
underrepresented groups
Companies
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com